CCM
ELV icon

CAAS Capital Management’s Elevance Health ELV Stock Holding History

CAAS Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,600
Closed -$772K – 880
2022
Q2 		$772K Buy
+1,600
New +$792K 0.04% 426
2021
Q2 		– Sell
-4,929
Closed -$1.77M – 1105
2021
Q1 		$1.77M Buy
+4,929
New +$1.59M 0.02% 631

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CAAS Capital Management's ELV Position: Q3 2022 in Review

CAAS Capital Management sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 1,600 shares — an estimated $772K sold.

CAAS Capital Management first reported a position in ELV in Q1 2021 and held it in 2 quarters. The position peaked at $1.77M in Q1 2021. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • CAAS Capital Management reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • CAAS Capital Management sold 1,600 Elevance Health shares in Q3 2022, an estimated $772K.
  • CAAS Capital Management first reported a position in Elevance Health in Q1 2021 and held it in 2 quarters.
  • CAAS Capital Management's Elevance Health position peaked at $1.77M in Q1 2021.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on CAAS Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.